SCHEDULE: Vanguard Group Reports Zero Vericel Corp Beneficial Ownership

The Vanguard Group has filed an amendment to its Schedule 13G, reporting zero beneficial ownership in Vericel Corp common stock following an internal organizational realignment.

Summary

• The Vanguard Group filed an Amendment No. 6 to its Schedule 13G regarding its beneficial ownership of Vericel Corp common stock.
• As of the event date March 13, 2026, The Vanguard Group reported 0.00 shares beneficially owned, representing 0% of the class.
• This change is due to an internal realignment within The Vanguard Group, Inc. on January 12, 2026.
• Certain subsidiaries or business divisions of The Vanguard Group, Inc. will now report beneficial ownership separately (on a disaggregated basis).
• The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by these subsidiaries and/or business divisions.
• The filing confirms that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Vericel Corp.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, primarily an administrative update regarding The Vanguard Group's internal reporting structure rather than a change in investment sentiment towards Vericel Corp.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding Vericel Corp's future performance or The Vanguard Group's future investment intentions beyond the reporting realignment.

Management Comments

• "On January 12, 2026, The Vanguard Group, Inc. went through an internal realignment. In accordance with SEC Release No. 34-39538 (January 12, 1998), certain subsidiaries or business divisions of subsidiaries of The Vanguard Group, Inc., that formerly had, or were deemed to have, beneficial ownership with The Vanguard Group, Inc., will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in reliance on such release."
• "Further in accordance with SEC Release No. 34-39538 (January 12, 1998), The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries and/or business divisions."

Industry Context

StockSavvy.ai notes that this filing represents a routine administrative update for a large institutional investor like The Vanguard Group. Such internal realignments and subsequent reporting changes are common and typically reflect organizational structure adjustments rather than a shift in investment strategy or sentiment towards the underlying company, Vericel Corp.

Stakeholder Impact

• Shareholders of Vericel Corp should be aware that The Vanguard Group, as the parent entity, no longer reports beneficial ownership of their common stock. However, this does not necessarily mean that Vanguard-managed funds have divested their holdings, as these are now reported by separate subsidiaries.

Key Dates

Keywords

Vericel Corp, Vanguard Group, Schedule 13G, Beneficial Ownership, Institutional Investor, Common Stock, SEC Filing